Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross-sectional Study to Investigate Prevalence of Systemic Inflammation (hsCRP) in Cohort of Patients With HF and a Cohort of Patients With ASCVD and CKD in the Middle East

NCT06655493 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT06655493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06655493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross-sectional Study to Investigate Prevalence of Systemic Inflammation (hsCRP) in Cohort of Patients With HF and a Cohort of Patients With ASCVD and CKD in the Middle East
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
November 22, 2024
Completion date
August 28, 2025
Enrollment
756 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

systemic inflammation (hscrp)